GlassScriptPhysician profile
Tilak Kr Pasala
NPI 1548493323
$28,634.58
in general payments reported to CMS, 2019-2025
27 companies · $6,754 in 2025
The $6,754 reported for 2025 was more than what 86% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $944 · 2021: $2,769 · 2022: $2,099 · 2023: $1,566 · 2024: $1,533 · 2025: $6,754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,361 · Travel and Lodging: $1,902 · Consulting Fee: $1,590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,360.84 |
| Travel and Lodging | $1,901.71 |
| Consulting Fee | $1,590.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $8,021.97 | 2019-2020 | |
| Edwards Lifesciences Corporation | $4,274.86 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Evoque |
| Abbott Laboratories | $4,238.30 | 2019-2025 | Triclip, Mitraclip, Amplatzer Amulet |
| Medtronic, INC. | $3,961.48 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Venaseal |
| Philips North America LLC | $2,337.21 | 2019-2025 | Igt Devices Undivided |
| Abiomed | $1,773.73 | 2022-2025 | Impella |
| Ancora Heart, INC. | $1,223.10 | 2019-2022 | |
| Boston Scientific Corporation | $545.47 | 2019-2023 | Accolade Sr |
| Biosense Webster, INC. | $451.17 | 2025 | Nuvision Ice Catheter |
| Shockwave Medical, INC | $324.47 | 2025 | |
| Cardiac Dimensions, INC. | $159.44 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $158.12 | 2019 | |
| W. L. Gore & Associates, INC. | $152.89 | 2021-2023 | Gore Cardioform Septal Occluder |
| Cook Medical LLC | $138.95 | 2019 | |
| Amgen INC. | $133.32 | 2024 | Repatha |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $125.28 | 2024 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $124.46 | 2025 | Camzyos |
| Siemens Medical Solutions USA, INC. | $109.61 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.73 | 2024 | Jardiance |
| Cardiva Medical, INC. | $72.02 | 2022 | |
| Kestra Medical Technology Services, INC. | $66.78 | 2024 | Assure Wcd |
| Chiesi USA, INC. | $44.56 | 2019-2025 | Kengreal |
| Daiichi Sankyo INC. | $21.57 | 2024 | Injectafer |
| Kiniksa Pharmaceuticals International, Plc | $19.57 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $18.57 | 2024 | Onpattro |
| Angiodynamics, INC. | $18.29 | 2021 | |
| Merck Sharp & Dohme LLC | $15.66 | 2024 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tilak Pasala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.